Does difluoromethylornithine prevent recurrence in low-risk superficial bladder cancer?

被引：0

作者：

Herr, Harry W.

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA

[2] Cornell Univ, Coll Med, New York, NY USA

来源：

NATURE CLINICAL PRACTICE UROLOGY | 2007年 / 4卷 / 05期

关键词：

bladder neoplasms; eflornithine; polyamines; primary prevention;

D O I：

10.1038/ncpuro0753

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：240 / 241

页数：2

共 50 条

[1] Does difluoromethylornithine prevent recurrence in low-risk superficial bladder cancer?
Harry W Herr
Nature Clinical Practice Urology, 2007, 4 : 240 - 241
[2] Best approach for low-risk superficial bladder cancer
Solsona, Eduardo
THESCIENTIFICWORLDJOURNAL, 2006, 6 : 2638 - 2645
[3] Expectant management of patients with low-risk superficial bladder cancer
Miller, Javier
Bhalani, Vishal
Baldwin, Nathan
Kouba, Erik
Wallen, Eric M.
Pruthi, Raj S.
JOURNAL OF UROLOGY, 2007, 177 (04): : 523 - 523
[4] Randomized prospective phase III trial of difluoromethylornithine vs placebo in preventing recurrence of completely resected low risk superficial bladder cancer
Messing, Edward
Kim, KyungMann
Sharkey, Francis
Schultz, Melissa
Parnes, Howard
Kim, Daniel
Saltzstein, Daniel
Wilding, George
JOURNAL OF UROLOGY, 2006, 176 (02): : 500 - 504
[5] A randomized prospective phase III trial of difluoromethylornithine (DFMO) vs placebo (P) in preventing recurrence of completely resected low risk superficial bladder cancer
Messing, EM
Kim, KM
Wilding, G
Sharkey, F
Parnes, H
Schultz, M
Kim, D
Saltzstein, D
Carbone, P
JOURNAL OF UROLOGY, 2005, 173 (04): : 249 - 249
[6] Does the probiotic L. casei help prevent recurrence after transurethral resection for superficial bladder cancer?
Michael A O'Donnell
Nature Clinical Practice Urology, 2008, 5 : 526 - 527
[7] Does the probiotic L. casei help prevent recurrence after transurethral resection for superficial bladder cancer?
O'Donnell, Michael A.
NATURE CLINICAL PRACTICE UROLOGY, 2008, 5 (10): : 526 - 527
[8] Intravesical installation of pharmaceutical agents to prevent recurrence and progression of superficial bladder cancer
Stamatiou, K.
Perletti, Gianpaolo
SCIENTIFIC CHRONICLES, 2020, 25 (02) : 266 - 277
[9] Low-risk superficial bladder tumors: further observations on conservative management
Nature Clinical Practice Urology, 2008, 5 (3): : 123 - 124
[10] BCG therapy reduces risk of recurrence in superficial bladder cancer
Katherine Sole
Nature Clinical Practice Urology, 2006, 3 (6): : 292 - 293

← 1 2 3 4 5 →